Our Vision
1. To Advance Fundamental and Applied Research
Execute rigorous, high-impact scientific inquiry into the mechanisms of drug loading, drug uptake within cellular internalization, and drug–targeted interactions of novel delivery systems.
2. To Foster Interdisciplinary Synergy
Cultivate a collaborative research environment that bridges the gap between basic sciences, engineering disciplines, pharmaceutical formulation and clinical applications.
3. To Train the Next Generation of Scientific Leaders
Provide rigorous mentorship and advanced research opportunities for undergraduate, post-graduate, and post-doctoral scholars within an rigorous academic ecosystem.
4. To Facilitate Clinical and Industrial Translation
Accelerate the transition of laboratory innovations into viable clinical candidates through strategic partnerships with healthcare providers and the pharmaceutical industry sectors.
Our research cluster focuses on the formulation development ofconventional solid, semi-solid, and liquid drug delivery systems. We focus on optimizing standard, commercially viable dosage forms, including nut mot limited to tablets, capsules, creams, gels, lotions, ointments, and liquid formulations.
Our research cluster conduct rigorous analytical characterization to evaluate the safety, quality, and efficacy of pharmaceutical products. We utilizes advanced instrumentation to assess physicochemical properties, drug-excipient compatibility, dissolution profiles, and long-term stability, ensuring all formulations meet stringent academic and regulatory standards.
Our research cluster is at the forefront of translational pharmaceutical science, pioneering the design, fabrication, and characterization of novel biomaterials and nanocarriers. We focus on engineering smart, stimuli-responsive, and targeted delivery vehicles to optimize pharmacokinetics, minimize systemic toxicity, overcome biological barriers, and enhance the therapeutic index of challenging macromolecular and small-molecule therapeutics.
Our comprehensive research portfolio in advanced drug delivery spans several core platform technologies, such as nanoparticle-based platforms; liposomal and vesicular carrier systems; electrospun nanofibers and nanoparticles; and macromolecular architectures & hydrogels systems.
Sustainability within our research ecosystem is maintained through a structured approach to funding longevity, infrastructure modernization, and ethical stewardship. We actively secure multi-year institutional, national, and international grants to maintain state-of-the-art core facilities.
We prioritize environmental and biological safety in our material designs, emphasizing green synthesis pathways and biodegradable polymers. This comprehensive infrastructure supports long-term research continuity, ensures ethical compliance, and provides a resilient foundation for enduring scientific contribution.
